MENU
PRTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prothena (PRTA) Ownership - Who owns Prothena?

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay, Block C
Phone
+353 12362500
Employees
67
Web
https://www.prothena.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
460.18M
P/E Ratio
N/A
Total Cash
329.46M
Projected Growth
N/A
Total Debt
7.65M
Revenue
57.94M
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
6.29
Total Debt/Equity
N/A
Revenue/Share
1.07 USD as % of share price
View a ticker or compare two or three
PRTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay, Block C
Phone
+353 12362500
Employees
67
Web
https://www.prothena.com